GSA Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $699K | Buy |
1,571
+837
| +114% | +$372K | 0.05% | 690 |
|
2025
Q1 | $356K | Sell |
734
-1,255
| -63% | -$609K | 0.03% | 1033 |
|
2024
Q4 | $801K | Buy |
+1,989
| New | +$801K | 0.06% | 559 |
|
2024
Q3 | – | Sell |
-652
| Closed | -$306K | – | 2039 |
|
2024
Q2 | $306K | Buy |
+652
| New | +$306K | 0.02% | 1275 |
|
2022
Q3 | – | Sell |
-1,670
| Closed | -$471K | – | 1894 |
|
2022
Q2 | $471K | Sell |
1,670
-1,743
| -51% | -$492K | 0.07% | 542 |
|
2022
Q1 | $891K | Buy |
3,413
+1,849
| +118% | +$483K | 0.12% | 225 |
|
2021
Q4 | $343K | Sell |
1,564
-895
| -36% | -$196K | 0.04% | 849 |
|
2021
Q3 | $446K | Buy |
2,459
+1,372
| +126% | +$249K | 0.05% | 764 |
|
2021
Q2 | $219K | Buy |
+1,087
| New | +$219K | 0.02% | 1138 |
|
2020
Q4 | – | Sell |
-1,037
| Closed | -$282K | – | 1634 |
|
2020
Q3 | $282K | Buy |
+1,037
| New | +$282K | 0.05% | 785 |
|
2020
Q2 | – | Sell |
-1,490
| Closed | -$355K | – | 1140 |
|
2020
Q1 | $355K | Sell |
1,490
-1,077
| -42% | -$257K | 0.09% | 372 |
|
2019
Q4 | $562K | Sell |
2,567
-7,105
| -73% | -$1.56M | 0.07% | 576 |
|
2019
Q3 | $1.64M | Buy |
9,672
+7,479
| +341% | +$1.27M | 0.22% | 36 |
|
2019
Q2 | $402K | Sell |
2,193
-2,002
| -48% | -$367K | 0.05% | 803 |
|
2019
Q1 | $772K | Sell |
4,195
-417
| -9% | -$76.7K | 0.08% | 438 |
|
2018
Q4 | $764K | Sell |
4,612
-7,743
| -63% | -$1.28M | 0.09% | 341 |
|
2018
Q3 | $2.38M | Sell |
12,355
-9,087
| -42% | -$1.75M | 0.13% | 173 |
|
2018
Q2 | $3.64M | Sell |
21,442
-12,129
| -36% | -$2.06M | 0.18% | 69 |
|
2018
Q1 | $5.47M | Buy |
33,571
+7,264
| +28% | +$1.18M | 0.29% | 17 |
|
2017
Q4 | $3.94M | Buy |
26,307
+9,194
| +54% | +$1.38M | 0.24% | 33 |
|
2017
Q3 | $2.6M | Sell |
17,113
-1,910
| -10% | -$290K | 0.18% | 82 |
|
2017
Q2 | $2.45M | Buy |
19,023
+11,523
| +154% | +$1.48M | 0.16% | 100 |
|
2017
Q1 | $820K | Sell |
7,500
-31,692
| -81% | -$3.46M | 0.04% | 771 |
|
2016
Q4 | $2.89M | Buy |
39,192
+22,369
| +133% | +$1.65M | 0.17% | 91 |
|
2016
Q3 | $1.47M | Buy |
16,823
+14,156
| +531% | +$1.23M | 0.08% | 385 |
|
2016
Q2 | $229K | Sell |
2,667
-45,339
| -94% | -$3.89M | 0.01% | 1513 |
|
2016
Q1 | $3.82M | Buy |
+48,006
| New | +$3.82M | 0.24% | 29 |
|
2015
Q4 | – | Sell |
-49,171
| Closed | -$5.12M | – | 1983 |
|
2015
Q3 | $5.12M | Buy |
49,171
+35,079
| +249% | +$3.65M | 0.25% | 42 |
|
2015
Q2 | $1.74M | Buy |
14,092
+7,118
| +102% | +$879K | 0.07% | 482 |
|
2015
Q1 | $823K | Sell |
6,974
-4,756
| -41% | -$561K | 0.03% | 1024 |
|
2014
Q4 | $1.39M | Buy |
+11,730
| New | +$1.39M | 0.1% | 281 |
|
2014
Q2 | – | Sell |
-76,548
| Closed | -$5.41M | – | 1975 |
|
2014
Q1 | $5.41M | Buy |
+76,548
| New | +$5.41M | 0.39% | 37 |
|
2013
Q4 | – | Sell |
-23,055
| Closed | -$1.75M | – | 1779 |
|
2013
Q3 | $1.75M | Sell |
23,055
-643
| -3% | -$48.8K | 0.14% | 148 |
|
2013
Q2 | $1.9M | Buy |
+23,698
| New | +$1.9M | 0.23% | 74 |
|